Amnioreduction for Pregnant Women with Polyhydramnios
Data Collection
Collected from today forward - ProspectiveUrogenital Diseases+1
+ Female Urogenital Diseases and Pregnancy Complications
+ Polyhydramnios
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: August 1, 2025
Actual date on which the first participant was enrolled.This study focuses on understanding how a procedure called amnioreduction can help manage pregnancies complicated by polyhydramnios, which is a condition where there is too much amniotic fluid around the baby. Polyhydramnios can happen in about 2% of pregnancies and can lead to problems like preterm birth or fetal abnormalities. This study is important because managing polyhydramnios can be challenging, especially in severe cases. Amnioreduction is known to reduce the risk of preterm labor, ease the mother's discomfort, and might help prolong the pregnancy, benefiting both the mother and the baby. During the study, participants undergo amnioreduction, which involves removing excess amniotic fluid to relieve symptoms and potentially improve pregnancy outcomes. The study observes and records the gestational age at which the baby is delivered, aiming for a longer pregnancy duration, which is considered beneficial. It also tracks the number of cases where a condition called premature rupture of membranes (PROM) occurs, as reducing this risk can lead to better pregnancy results. By understanding these outcomes, the study aims to provide insights into the benefits and risks of amnioreduction, helping to improve care for those with polyhydramnios.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.28 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location